Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Sale of 627 STOK shares, $16.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Stoke Therapeutics, Inc. (STOK) | Sale | 627 | $16.5K |
| Aug 19, 2026 | Stoke Therapeutics, Inc. (STOK) | Exercise/Conversion | 6,000 | n/a |
| Jun 18, 2026 | Stoke Therapeutics, Inc. (STOK) | Sale | 1,457 | $43.6K |
| Mar 24, 2026 | Stoke Therapeutics, Inc. (STOK) | Sale | 8,692 | $292.4K |
| Mar 19, 2026 | Stoke Therapeutics, Inc. (STOK) | Sale | 2,476 | $81.1K |
| Mar 17, 2026 | Stoke Therapeutics, Inc. (STOK) | Exercise/Conversion | 7,475 | n/a |
| Feb 19, 2026 | Stoke Therapeutics, Inc. (STOK) | Grant/Award | 53,000 | n/a |
| Dec 10, 2025 | Stoke Therapeutics, Inc. (STOK) | Sale | 1,300 | $41.1K |
| Dec 6, 2025 | Stoke Therapeutics, Inc. (STOK) | Exercise/Conversion | 6,000 | n/a |
| Dec 4, 2025 | Stoke Therapeutics, Inc. (STOK) | Exercise/Conversion | 12,357 | n/a |